Table 5.
Study | Interventional technique | Study design | Inclusion group | Method | Observations | Affiliation or disclosure |
---|---|---|---|---|---|---|
Naja et al.[30] | Paravertebral block | Case report | Mainly T1 extending to T4 | Single injection at T1-T2 levels paravertebral catheter placement at T3 level. Bupivacaine 0.5% (19 mL) and clonidine 150 μg/mL (1 mL); repeated injection of same solution QOD for 3 weeks. | Before: VAS 7–8/10 with mood changes and sleep disturbance even while using ACT, NSAIDs, tramadol, carbamazepine 1200 mg/day, amitriptyline 30 mg/day, and gabapentin 3600 mg/day. After: pain free during an 8-month follow-up period. | Nil |
Ding et al.[33] | SGB and SG-pulsed RFA followed for 6 months duration | RCT total 84, 48 each in two groups | PHN on the face or upper limbs more than 1 month duration | CT-guided SGB vs. SG-pulsed RFA, only once | VAS decreased in both groups (P < 0.05). In the SG-B group, VAS increased after 1 month, whereas in the SG-P group, VAS gradually decreased at later follow-up time points. VAS decreased more significantly in the SG-P group (P < 0.05). The total effective rates of the SG-B and SG-P groups were 64.3 and 83.3%, respectively. | This study was supported by the Natural Science Foundation of Liaoning Province (No. 20170541032) and Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Plan (No. RC170045). |
Milligan and Nash[34] | SGB | Observational study, 34 had PHN more 1 year duration and 8 had PHN < 1 year duration | PHN of thoracic, cervical, or trigeminal distribution. | 65 SGB done on 42 patients. | Landmark-based SGB: anterior paratracheal approach to the ganglion was used, and 10 mL 0.25% bupivacaine injected. | 12 (29%) showed no improvement, 11 (26%) were improved, and 19 (45%) had a good result. Patients with PHN < 1-year duration had better results. |
One patient received nine blocks. |
ACT = acetaminophen, QOD = once every 2 days